A celebration of the inspirational figures behind innovation and achievement in pathology and laboratory medicine
12/20/2015 | Christopher Chapman
Circulating tumor cells may hold information crucial for better pancreatic cancer diagnosis and treatment – but locating them needs special tactics
12/18/2015 | Xia-Jun Ma
RNA in situ hybridization offers a new way to overcome the challenges of advancing RNA cancer biomarkers to the clinic
12/18/2015 | Roisin McGuigan
We Sit Down With Michael Wells, Past President of the European Society of Pathology.
Over 90 percent of the human cutaneous virome is made up of unclassifiable “dark matter”
11/30/2015 | Giuseppe Banfi
Physical activity is an important preanalytical variable in blood analysis and here’s why.
10/26/2015 | Eshwar Mahenthiralingam
Molecular techniques can offer rapid, accurate diagnosis of lung infections in cystic fibrosis, but most labs feel the technologies are out of reach. What if there was an affordable alternative?
10/25/2015 | Patrick Pauwels
New technologies and molecular discoveries are changing the way diagnoses are made. But how will already burdened molecular pathology labs cope with more cases and restricted budgets?
10/25/2015 | Mads Nybo
Why we need to harmonize fasting definitions for blood sampling
10/23/2015 | Roisin McGuigan
Gene expression panel could help breast cancer patients with a low risk of recurrence avoid unnecessary chemotherapy
09/30/2015 | Roisin McGuigan
Keith Miller is Director and co-founder of CADQAS (Cancer Diagnostic Quality Assurance Services), a not-for-profit community interest company hosted by Poundbury Cancer Institute (PCI).
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Genetic Counseling
The Future Lies in Phenomic Medicine
Trusted Bodies for PGx